XML 78 R62.htm IDEA: XBRL DOCUMENT v3.23.1
Stock-based compensation (FY) (Tables)
3 Months Ended 12 Months Ended
Mar. 31, 2023
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]    
Assumptions used to estimate fair value of stock options granted   The assumptions used to estimate the fair value of stock options granted during the years ended December 31, 2022, 2021 and 2020 are as follows:
 
​ ​
Year ended December 31,
 
​ ​
2022
​ ​
2021
​ ​
2020
Expected dividend yield
​ ​
—
​ ​
—
​ ​
—
Expected volatility
​ ​
36.6%
​ ​
56.3%
​ ​
45.0%
Expected term (years)
​ ​
6.1
​ ​
8.5
​ ​
9.4
Risk-free interest rate
​ ​
3.0%
​ ​
0.9%
​ ​
0.43%
Stock option activity

The following table summarizes the Company’s stock option activity during the periods presented (in thousands except share and per share data):
 
​ ​
Number of
options
outstanding
​ ​
Weighted average
exercise price
($)
​ ​
Weighted
average
remaining
contractual term
(years)
​ ​
Aggregate
intrinsic value
($)
Balance as of December 31, 2022
​ ​
15,387,546
​ ​
$1.76
​ ​
7.12
​ ​
$8,763
Granted
​ ​
—
​ ​
—
​ ​
 
​ ​
 
Exercised
​ ​
(672,583)
​ ​
0.81
​ ​
 
​ ​
40
Forfeited
​ ​
(45,731)
​ ​
1.14
​ ​
 
​ ​
 
Expired
​ ​
(26,821)
​ ​
0.81
​ ​
 
​ ​
 
Balance as of March 31, 2023
​ ​
14,642,411
​ ​
$1.72
​ ​
7.45
​ ​
 
Options exercisable as of March 31, 2023
​ ​
11,919,869
​ ​
$1.02
​ ​
6.67
​ ​
 
Options unvested as of March 31, 2023
​ ​
3,544,841
​ ​
$3.84
​ ​
8.75
​ ​
 

The following table summarizes the Company’s stock option activity during the periods presented (in thousands except share and per share data):
 
​ ​
Number of
options
​ ​
Weighted average
exercise price
($)
​ ​
Weighted
average
remaining
contractual term
(years)
​ ​
Aggregate
intrinsic value
($)
Outstanding as of December 31, 2020
​ ​
12,654,807
​ ​
0.81
​ ​
9.38
​ ​
—
Granted
​ ​
4,369,866
​ ​
0.82
​ ​
—
​ ​
—
Exercised
​ ​
(105,203)
​ ​
0.81
​ ​
—
​ ​
—
Cancelled
​ ​
(171,204)
​ ​
0.81
​ ​
—
​ ​
—
Forfeited
​ ​
(412,132)
​ ​
0.81
​ ​
—
​ ​
—
Outstanding as of December 31, 2021
​ ​
16,336,134
​ ​
0.81
​ ​
8.55
​ ​
80,179
Granted
​ ​
1,500,081
​ ​
10.07
​ ​
—
​ ​
—
Exercised
​ ​
(1,380,609)
​ ​
0.81
​ ​
—
​ ​
1,981
Forfeited
​ ​
(1,050,228)
​ ​
1.43
​ ​
—
​ ​
—
Expired
​ ​
(17,832)
​ ​
0.81
​ ​
—
​ ​
—
Outstanding as of December 31, 2022
​ ​
15,387,546
​ ​
1.76
​ ​
7.12
​ ​
8,763
Options exercisable as of December 31, 2022
​ ​
11,309,426
​ ​
0.89
​ ​
6.53
​ ​
7,056
Options unvested as of December 31, 2022
​ ​
4,076,090
​ ​
3.86
​ ​
8.74
​ ​
1,706
Preferred stock warrants outstanding and exercisable  

As of December 31, 2022, the following preferred stock warrants of D-Wave Systems were outstanding and exercisable:
 
​ ​
Number of
warrants
outstanding
​ ​
Weighted
average exercise
price ($)
​ ​
Expiry Date
​ ​
Number
exercisable
 
​ ​
3,247,637
​ ​
1.92
​ ​
29-Nov-26
​ ​
1,299,055
Total, December 31, 2022
​ ​
3,247,637
​ ​
1.92
​ ​
​ ​
1,299,055
RSU activity and related information

The following table summarizes the RSU activity and related information under the 2022 Plan:
 
​ ​
Number of
Outstanding
​ ​
Weighted average
Grant Date Fair
Value ($)
Unvested as of December 31, 2022
​ ​
8,143,304
​ ​
$5.69
Granted
​ ​
3,492,520
​ ​
0.54
Forfeited
​ ​
(130,619)
​ ​
—
Vested
​ ​
—
​ ​
—
Unvested as of March 31, 2023
​ ​
11,505,205
​ ​
$4.11
Expected to vest as of March 31, 2023
​ ​
10,644,546
​ ​
$4.15
The following table summarizes the RSU activity and related information under the 2022 Plan:
 
​ ​
Number of
Outstanding
​ ​
Weighted average
Grant Date Fair
Value ($)
Unvested as of December 31, 2021
​ ​
—
​ ​
$   —
Granted
​ ​
8,278,317
​ ​
5.72
Forfeited
​ ​
(135,013)
​ ​
0.12
Vested
​ ​
—
​ ​
—
Unvested as of December 31, 2022
​ ​
8,143,304
​ ​
$5.69
Stock-based compensation expense

The following table summarizes the stock-based compensation expense classified in the condensed consolidated statements of operations and comprehensive loss as follows (in thousands):
 
​ ​
Three months ended March 31,
 
​ ​
2023
​ ​
2022
Cost of revenue
​ ​
$377
​ ​
$32
Research and development
​ ​
2,760
​ ​
60
General and administrative
​ ​
3,294
​ ​
629
Sales and marketing
​ ​
324
​ ​
62
Total stock-based compensation
​ ​
$6,755
​ ​
$783

The following table summarizes the stock-based compensation expense classified in the consolidated statements of operations and comprehensive loss as follows (in thousands):
 
​ ​
Year ended December 31,
 
​ ​
2022
​ ​
2021
​ ​
2020
Cost of revenue
​ ​
$379
​ ​
$41
​ ​
$49
Research and development
​ ​
3,141
​ ​
297
​ ​
1,464
General and administrative
​ ​
2,615
​ ​
1,164
​ ​
1,346
Sales and marketing
​ ​
3,029
​ ​
237
​ ​
130
Total stock-based compensation
​ ​
$9,164
​ ​
$1,739
​ ​
$2,989